This study was crucial in defining RPRD2 as a host restriction factor by clearly showing its antiviral effect against HIV-1, HIV-2, and SIV, explaining its mechanism of blocking HIV infection by reducing the levels of reverse transcripts produced, and confirming it is counter-targeted by the incoming virus. The gene discussed is RPRD2; the disease is HIV infectious disease.